Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v6-EN
Language French English
Date Updated 2021-12-08 2019-08-23
Drug Identification Number 02244757 02244757
Brand name TRIZIVIR TRIZIVIR
Common or Proper name abacavir (as abacavir sulfate), lamivudine and zidovudine tablets abacavir (as abacavir sulfate), lamivudine and zidovudine tablets
Company Name VIIV HEALTHCARE ULC VIIV HEALTHCARE ULC
Ingredients ZIDOVUDINE ABACAVIR LAMIVUDINE ZIDOVUDINE ABACAVIR LAMIVUDINE
Strength(s) 300MG 300MG 150MG 300MG 300MG 150MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 60's 60's
ATC code J05AR J05AR
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-08-23 2019-08-23
Estimated end date Unknown Unknown
Actual end date 2019-09-17
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments This product has been discontinued.
Health Canada comments